👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
All content for Inside Lyme Podcast with Dr. Daniel Cameron is the property of Dr. Daniel Cameron and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
Could Chronic Lyme Disease Pain Be a Missing Piece in America’s Pain Crisis?
Inside Lyme Podcast with Dr. Daniel Cameron
5 minutes
2 months ago
Could Chronic Lyme Disease Pain Be a Missing Piece in America’s Pain Crisis?
I’m Dr. Daniel Cameron. In my practice, I often see patients with chronic pain, and I want to explore whether chronic Lyme disease could be part of the puzzle behind America’s growing pain epidemic. A recent paper by Jovkovich in Pain reported that chronic pain prevalence in U.S. adults rose from 21% in 2019 to 24% in 2023—affecting 60 million people. Only about 13% of this increase was linked to long COVID. The rest remains unexplained. Overlap Between Lyme Pain and National Pain Trends T...
Inside Lyme Podcast with Dr. Daniel Cameron
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
